Role and development of GLP-1 receptor agonists in the management of diabetes
Chee W Chia, Josephine M EganNational Institutes of Health, National Institute on Aging, Intramural Research Program, Baltimore, Maryland, USAAbstract: Glucagon-like peptide-1 (GLP-1) is a hormone secreted from enteroendocrine L cells of the intestine in response to food. Exogenous GLP-...
Guardado en:
Autores principales: | Chee W Chia, Josephine M Egan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/557b3719c76d42cf8151d5df75f42c68 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Emerging role of GLP-1 receptor agonists in the treatment of obesity
por: Lisa M Neff, et al.
Publicado: (2010) -
Comparison of extended release GLP-1 receptor agonist therapy versus sitagliptin in the management of type 2 diabetes
por: Stolar MW, et al.
Publicado: (2013) -
Emerging role of GLP-1 receptor agonists in the treatment of obesity
por: Neff LM
Publicado: (2010) -
Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine
por: Lindsay Zilliox, et al.
Publicado: (2010) -
Peroxisome proliferator-activated receptors as stimulants of angiogenesis in cardiovascular disease and diabetes
por: Cyrus V Desouza, et al.
Publicado: (2009)